PO.ET06.06 · 实验与分子治疗
Tumor Diagnostics, Prognostics, and Therapeutic Outcomes
-
-
- 7211 7211 High intratumoral homogeneity and tumor specificity makes uroplakin 3b (Upk3b) a promising therapeutic targetin malignant mesothelioma Sönke von Weihe, Frank Elsholz, Philipp Busch, Fiete Gehrisch, Nina Schraps, Martina Kluth, Maria C. Tsourlakis, Katharina Möller, Maximilian Lennartz, Veit Bertram, Florian Viehweger, Florian Lutz, Birgit Hantzsch-Kuhn, Till Olchers, David B. Ellebrecht, Christoph Fraune, Ronald Simon, Guido Sauter, Martin Reck, Stefan Steurer
-
-
-
-
-
-
- 7218 7218 Preliminary exploration of the synergistic mechanism between EBV LMP1 and MYD88 L265P mutation on the efficacy of PD-1 Inhibitors in ABC-DLBCL Chang Wang, Yingtao Lin, Jiesong Wang
-
-
- 7223 7223 Evaluating treatment-related estrogen signaling and molecular subtype heterogeneity in a racially diverse HR-positive breast cancer cohort Abigail M. Fielder, Gregory Dyson, Julie Ruterbusch, David Carr, Julie Boerner, Ann G. Schwartz, Kristen S. Purrington
- 7224 7224 Nuclear/cytoplasmic translocation of beta-Catenin protein is a strong predictor of unfavorable patient prognosis in ERG negative but not in ERG positive prostate cancer Florian Lutz, Osman Gökalp, Ronald Simon, Hans Heinzer, Alexander Haese, Sarah Minner, Guido Sauter, Thorsten Schlomm, Martina Kluth, Claudia Hube-Magg
-
-
- 7227 7227 NECTIN4-a mplified breast cancer targeted by Zelenectide Pevedotin: Amplification and expression are frequent, concordant, and stable Alexander Azizi, Niklas Klümper, Emma Colliver, Alexander Quaas, Birgid Schoemig-Markiefka, Arndt Hartmann, Christoph Kuppe, Manuel Ritter, Viktor Grünwald, Michael Hölzel, Chris Bailey, Gustavo Arruda Bezerra, Nicholas Guthertz, Sergey Nikolaev, Fabrice Andre, Charles Swanton, Johannes Braegelmann, Markus Eckstein
-
-
-
